Rights

REDWOOD CITY, Calif., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced that Sanofi has provided…

At the close of business on 06 December 2022, Morten Opstad, Chair of the Board of IDEX Biometrics ASA, held the following voting rights in IDEX, for the purpose of the Extraordinary General Meeting on 09 December 2022: Total…

In Conjunction with Collection Launch, Reebok to Donate $600,000 to RISE, a national nonprofit that educates and empowers the sports community to eliminate racial discrimination and champion social justice(BOSTON) December 6, 2022 –…

VALNEVA Declaration of shares and voting rightsNovember 30, 2022 __________________________________________________________________________________________ Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800…

Company announcement – No. 54 / 2022 Total number of shares and voting rights in Zealand Pharma at November 30, 2022 Copenhagen, Denmark and Boston, MA, U.S. November 30, 2022 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no.…

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Block, Inc. (NYSE: SQ) between November 4, 2021 and April 4, 2022, both dates inclusive (the “Class Period”), of…

The board of directors of IDEX Biometrics ASA has resolved to issue in total 246,167 ordinary shares at price NOK 0.15 per share to an employee who has exercised incentive subscription rights. The incentive subscription rights were…

In Bernin, on November 8, 2022 INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES FORMING THE SHARE CAPITAL (Article L. 233-8 II of the French Commercial Code and article 223-16 of the General…

VALNEVA Declaration of shares and voting rightsOctober 31, 2022 __________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800…

Negma Group has converted 120 convertible bonds in Oxurion resulting in a EUR 300,000 capital increase. This is part of Negma Group’s EUR 30 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and…